Clinical Trials Browser

Terminated × Carcinoma, Transitional Cell × Bevacizumab × Clear all

NCT03272217 2025-01-07

Atezolizumab With Bevacizumab in Previously Untreated Metastatic/Unresectable Urothelial Cancer

Phase 2 Terminated

16 enrolled 12 charts

Carcinoma, Transitional Cell